Literature DB >> 30501987

Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma?

Jae P Jung1, Mazen S Zenati1, Ahmad Hamad1, Melissa E Hogg1, Richard L Simmons1, Amer H Zureikat1, Herbert J Zeh2, Brian A Boone3.   

Abstract

BACKGROUND: Achieving margin negative resection is a significant determinant of outcome in pancreatic adenocarcinoma (PDA). However, because of the fibrotic nature of PDA, it can be difficult to discriminate fibrosis from active disease intra-operatively. We sought to determine if post-hoc video review of robotic pancreatico-duodenectomy (RPD) could predict the portal/superior mesenteric vein (PV/SMV) margin status on final pathology.
METHODS: Experienced pancreatic surgeons, blinded to patient and operative variables, reviewed the PV/SMV margin for available RPD videos of consecutive PDA patients from 9/2012 through 6/2017.
RESULTS: 107 RPD videos were reviewed. Of 76 patients (71%) predicted to have a negative vein margin on video review, 20 patients (26%) had a pathologic positive margin. 25 of 31 patients (81%) predicted to have positive margin on video review were positive on pathology. The specificity of video prediction was 90.3% with a sensitivity of 55.6% and an accuracy of 75.7%.
CONCLUSION: Post-hoc video review prediction is unable to reliably predict a positive (R1) margin at the portal vein/SMV, suggesting that intra-operative clinical assessment may be suboptimal in determining the need for more extensive resections.
Copyright © 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30501987      PMCID: PMC6631331          DOI: 10.1016/j.hpb.2018.10.012

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  38 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 2.  Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.

Authors:  M D Chandrasegaram; D Goldstein; J Simes; V Gebski; J G Kench; A J Gill; J S Samra; N D Merrett; A J Richardson; A P Barbour
Journal:  Br J Surg       Date:  2015-09-09       Impact factor: 6.939

3.  Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.

Authors:  Y Murakami; S Satoi; F Motoi; M Sho; M Kawai; I Matsumoto; G Honda
Journal:  Br J Surg       Date:  2015-04-15       Impact factor: 6.939

4.  Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients.

Authors:  Linda M Youngwirth; Daniel P Nussbaum; Samantha Thomas; Mohamed A Adam; Dan G Blazer; Sanziana A Roman; Julie A Sosa
Journal:  J Surg Oncol       Date:  2017-04-13       Impact factor: 3.454

5.  Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins.

Authors:  Jonathan Hernandez; John Mullinax; Whalen Clark; Paul Toomey; Desiree Villadolid; Connor Morton; Sharona Ross; Alexander Rosemurgy
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

Review 6.  Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: Does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review.

Authors:  Niccolo' Petrucciani; Giuseppe Nigri; Tarek Debs; Giulia Giannini; Elena Sborlini; Laura Antolino; Paolo Aurello; Francesco D'Angelo; Jean Gugenheim; Giovanni Ramacciato
Journal:  Pancreatology       Date:  2016-09-13       Impact factor: 3.996

7.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

Review 8.  A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma.

Authors:  James R Butler; Syed A Ahmad; Matthew H Katz; Jessica L Cioffi; Nicholas J Zyromski
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

9.  Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.

Authors:  Jiansheng Wang; Jeannelyn S Estrella; Lan Peng; Asif Rashid; Gauri R Varadhachary; Hua Wang; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Matthew H Katz; Henry F Gomez; Douglas B Evans; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

10.  The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Nigel B Jamieson; Nigel I J Chan; Alan K Foulis; Euan J Dickson; Colin J McKay; C Ross Carter
Journal:  J Gastrointest Surg       Date:  2013-01-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.